Supernus Pharmaceuticals Inc Strategic Asset Allocation Index
Supernus Pharmaceuticals Inc strategic asset allocation index. Supernus Pharmaceuticals Inc (SUPN) has a Strategic Asset Allocation Index of 0.0% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $1.04 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Supernus Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Supernus Pharmaceuticals Inc (2011–2024)
Strategic asset allocation index of Supernus Pharmaceuticals Inc from 2011 to 2024. This chart shows how Supernus Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 14 annual periods from 2011 to 2024. As of December 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $1.04 Billion USD.
Supernus Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2011–2024)
Supernus Pharmaceuticals Inc strategic asset allocation index by year from 2011 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Supernus Pharmaceuticals Inc from 2011 to 2024, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see SUPN company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $1.04 Billion | ▼ -1.8 pp |
| 2023 | 1.8% | $16.62 Million | $- | $16.62 Million | $921.52 Million | ▼ -13.8 pp |
| 2022 | 15.6% | $137.97 Million | $44.08 Million | $93.90 Million | $886.20 Million | ▼ -5.5 pp |
| 2021 | 21.0% | $171.49 Million | $52.32 Million | $119.17 Million | $815.85 Million | ▼ -31.1 pp |
| 2020 | 52.1% | $388.18 Million | $37.82 Million | $350.36 Million | $744.86 Million | ▼ -50.1 pp |
| 2019 | 102.3% | $608.84 Million | $17.07 Million | $591.77 Million | $595.43 Million | ▲ +8.9 pp |
| 2018 | 93.3% | $422.89 Million | $4.09 Million | $418.80 Million | $453.02 Million | ▲ +41.5 pp |
| 2017 | 51.9% | $138.76 Million | $5.12 Million | $133.64 Million | $267.48 Million | ▲ +10.3 pp |
| 2016 | 41.6% | $79.75 Million | $4.34 Million | $75.41 Million | $191.75 Million | ▼ -7.9 pp |
| 2015 | 49.5% | $58.88 Million | $3.87 Million | $55.01 Million | $118.88 Million | ▲ +18.3 pp |
| 2014 | 31.2% | $22.26 Million | $2.45 Million | $19.82 Million | $71.35 Million | ▼ -2.6 pp |
| 2013 | 33.8% | $11.31 Million | $2.55 Million | $8.76 Million | $33.46 Million | ▲ +31.3 pp |
| 2012 | 2.5% | $1.42 Million | $1.42 Million | $- | $57.57 Million | ▼ -11.4 pp |
| 2011 | 13.9% | $1.31 Million | $1.31 Million | $- | $9.44 Million | — |